DrugPatentWatch Archives
Click here to return to the current data set
|
DrugPatentWatch concentrates deep knowledge on more than 6,400 small-molecule drugs and 2,300 generic ingredients from 1,700 branded and generic pharmaceutical companies and 700 suppliers, and more than 4,300 active and expired US patents and 74,000 international patents spanning 93 countries and regional patent offices. |
Generic Name: ibandronate sodium
Summary for Generic Name: ibandronate sodium
|
Tentative approvals for IBANDRONATE SODIUM
| ||||||||||||||||||||||||||||||
Clinical Trials for: ibandronate sodiumBioequivalence Study of Ibandronate Sodium Tablets 150 mg Under Fasting Condition Status: Completed Condition: Healthy BONVIVA(Ibandronate) PMS(Post-marketing Surveillance ) Status: Completed Condition: Osteoporosis BONVIVA(Ibandronate) Injection PMS(Post-marketing Surveillance) Status: Completed Condition: Osteoporosis BONCURE Study: A Study of Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis on Bisphosphonate Therapy. Status: Completed Condition: Post-Menopausal Osteoporosis A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Previously Treated With Bonviva Status: Completed Condition: Post-Menopausal Osteoporosis BEATRIS Study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women With Post-Menopausal Osteoporosis Status: Completed Condition: Post-Menopausal Osteoporosis Courtesy of ClinicalTrials.org See more clinical trials for this drug | |||||||||||||||||||||||||||||||
Glossary
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Type | RLD | Patent No. | Patent Expiration | Patented / Exclusive Use | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Roche | BONIVA | ibandronate sodium | INJECTABLE; INTRAVENOUS | 021858 | Jan 6, 2006 | RX | Yes | <disabled> | NEW CHEMICAL ENTITY | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Roche | BONIVA | ibandronate sodium | INJECTABLE; INTRAVENOUS | 021858 | Jan 6, 2006 | RX | Yes | <disabled> | NEW DOSAGE FORM | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Roche | BONIVA | ibandronate sodium | INJECTABLE; INTRAVENOUS | 021858 | Jan 6, 2006 | RX | Yes | 4,927,814 | <disabled> | TREATMENT AND PREVENTION OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Roche | BONIVA | ibandronate sodium | INJECTABLE; INTRAVENOUS | 021858 | Jan 6, 2006 | RX | Yes | 5,662,918 | <disabled> | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| The preview shows a limited data set. Complete access is available with a Subscription | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
« Back to Dashboard
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Connect with Social Media:
Copyright © 2002-2013 thinkBiotech LLC. ISSN: 2162-2639
`abc